Albert Lowe
Stock Analyst at Craig-Hallum
(0.05)
# 2727
Out of 5,372 analysts
9
Total ratings
22.22%
Success rate
-7.37%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NGNE Neurogene | Initiates Coverage On: Buy | 50 | 18.4 | 171.74% | 1 | Jun 17, 2025 | |
ATOS Atossa Therapeutics | Initiates Coverage On: Buy | 4 | 0.81 | 393.83% | 1 | Jun 5, 2025 | |
IRD Opus Genetics | Initiates Coverage On: Buy | 6 | 0.93 | 545.16% | 1 | Apr 11, 2025 | |
SKYE Skye Bioscience | Maintains: Buy | 18 14 | 2.07 | 576.33% | 2 | Mar 21, 2025 | |
SABS SAB Biotherapeutics | Initiates Coverage On: Buy | 11 | 1.7 | 547.06% | 1 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 3.71 | 115.63% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 4 | 0.86 | 365.12% | 1 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 6 | 1.09 | 450.46% | 1 | May 13, 2024 |